Aldeyra Therapeutics to Present at the Oppenheimer & Co. 30th Annual Healthcare Conference
March 03 2020 - 8:00AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced that David McMullin,
Chief Commercial Officer of Aldeyra, will present at Oppenheimer
& Co.’s 30th Annual Healthcare Conference in New York City. The
presentation is scheduled to begin at 10:55 a.m. (ET) Tuesday,
March 17, 2020.
A live webcast of the presentation can be accessed on the
“Investors & Media” section of the Aldeyra website,
https://ir.aldeyra.com/. An audio replay will be available
following the live presentation and will be archived on the website
for 90 days.
About Aldeyra Therapeutics
Aldeyra Therapeutics is a biotechnology company devoted to
developing and commercializing next-generation medicines to improve
the lives of patients with immune-mediated diseases. Aldeyra's lead
investigational drug product candidates are potential
first-in-class treatments in development for dry eye disease,
allergic conjunctivitis, proliferative vitreoretinopathy, and
Sj�gren-Larsson Syndrome. The company is also developing other
product candidates for retinal and systemic inflammatory
diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200303005212/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com
Investor & Media Contact: Scott Solomon Sharon
Merrill Associates, Inc. Tel: 617-542-5300
ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024